NASDAQ (USD): Citius Pharmaceuticals, Inc. (CTXR)
Last Price
0.147
Today's Change
+0.013 (9.70%)
Day's Change
0.131 - 0.184
Trading Volume
141,016,082
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Hyundai unveils Big Electric SUV in Fast-growing Market
2
Bitcoin Climbs Closer to US$100,000 on Trump’s Support for Crypto
3
Starbucks Shrank Retail Staff 8% Despite Hundreds of New Stores
4
Starbucks Said to Consider Selling Stake in Chinese Business
5
US Senate Rejects Bids to Block Military Sales to Israel
#
Stock
Score
BABA
Alibaba Group Holding Limited
PLTR
Palantir Technologies Inc.
782
AGN
652
TSLA
Tesla, Inc.
TECS
Direxion Daily Technology Bear 3X Shares
434
6
SPXS
Direxion Daily S&P 500 Bear 3X Shares
7
ORCL
Oracle Corporation
8
AM
Antero Midstream Corporation
9
AAPL
Apple Inc.
10
TMS
260
Last
Change
Volume
MSTZ
1.05
+0.103
530,624,749
KULR
0.729
+0.284
441,647,985
ELAB
0.016
-0.004
265,847,001
RGTI
2.73
+0.991
261,611,791
NVDA
136.78
-5.17
221,626,610
SMCI
37.42
+4.27
142,666,808
CTXR
+0.013
QUBT
7.01
+0.91
125,367,927
LMDX
-0.018
120,553,903
MARA
26.03
0.00
113,213,743
BRK-A
718,207.52
+3,927.50
2,343
NVR
9,285.00
+277.76
20,659
MELI
2,094.78
+89.78
346,425
PABD
52.98
+52.98
BRHY
51.54
+51.54
393
COKE
1,302.49
+42.57
28,741
BLD
407.56
+34.51
310,756
QOWZ
34.32
+34.32
449
GHC
960.10
+34.28
4,248
BGRO
33.27
+33.27
52
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
TPL
1,614.05
-115.95
360,325
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
OLED
172.28
-40.39
1,254,445
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....